Aug 16, 2010, 07.15 PM IST
Marksans Pharma reports Rs 42.06 crore turnover for quarter ended Jun 2010
Marksans Pharma has reported a sales turnover of Rs 42.06 crore and a net profit of Rs 1.21 crore for the quarter ended Jun 2010
Like this story, share it with millions of investors on M3
Marksans Pharma reports Rs 42.06 crore turnover for quarter ended Jun 2010
Marksans Pharma has reported a sales turnover of Rs 42.06 crore and a net profit of Rs 1.21 crore for the quarter ended Jun 2010
Like this story, share it with millions of investors on M3
Marksans Pharma reports Rs 42.06 crore turnover for quarter ended Jun 2010
Marksans Pharma has reported a sales turnover of Rs 42.06 crore and a net profit of Rs 1.21 crore for the quarter ended Jun 2010
Share . Email . Print . A+A-
Marksans Pharma has reported a sales turnover of Rs 42.06 crore and a net profit of Rs 1.21 crore for the quarter ended Jun 2010.
| For the quarter ended Jun 2009 the sales turnover was Rs 45.82 crore and net loss was Rs 3.45 crore.
|
| | | Quarterly Results of Marksans Pharma | -------- in Rs. Cr. -------- |
| | Jun '09 | | | Mar '10 | Jun '10 | | Sales Turnover | 45.82 | | | 57.12 | 42.06 | | Other Income | -- | | | -- | -- | | Total Income | 45.82 | | | 57.12 | 42.06 | | Total Expenses | 42.51 | | | 44.12 | 34.43 | | Operating Profit | 3.31 | | | 13.00 | 7.63 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -- | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 3.31 | | | 13.00 | 7.63 | | Interest | 4.29 | | | 5.13 | 3.96 | | PBDT | -0.99 | | | 7.87 | 3.67 | | Depreciation | 2.43 | | | 2.45 | 2.46 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | -3.42 | | | 5.42 | 1.21 | | Tax | 0.03 | | | 0.34 | -- | | Net Profit | -3.45 | | | 5.08 | 1.21 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | -- | | | 0.14 | 0.03 | | Book Value | -- | | | -- | -- | | Equity | 36.78 | | | 36.78 | 36.78 | | Reserves | -- | | | -- | -- | | Face Value | 1.00 | | | 1.00 | 1.00 | | Source : Religare Technova |
|
|
From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'
The latest earning numbers FIRST on CNBC-TV18
|
